Evogene (EVGN) Stock Statistics & Valuation Metrics

Evogene has a market cap or net worth of $10.54M. The enterprise value is $11.80M.

Evogene has 6,672,173 shares outstanding. The number of shares has decreased by -2.65% in one year.

Evogene’s return on equity (ROE) is 11.36 and return on invested capital (ROIC) is -69.16%.

The current PE Ratio of Evogene is -0.65. Evogene’s PEG ratio is 0.18.

In the last 12 months, Evogene had revenue of 8.51M and earned -16.48M in profits. Earnings per share was -2.89.

In the last 12 months, operating cash flow was -19.70M and capital expenditures -626.00K, giving a free cash flow of -20.33M billion.

Evogene pays an annual dividend of ―, resulting in a dividend yield of ―

Evogene upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.

Evogene as a current ratio of 1.15, with Debt / Equity ratio of 42.71%

In the past 12 months, Evogene has paid 9.00K in taxes.

Evogene EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.40.

Evogene has $15.31M in cash and marketable securities with $12.87M in debt, giving a net cash position of -$2.44M billion.

Gross margin is 45.73%, with operating margin of -260.96%, and net profit margin of -193.69%.

The average price target for Evogene is $3.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy